Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

<< Previous

Bullboard Posts

Next >>

Post by subaru1ion May 02, 2024 7:39am

47 Views

Post# 36018981

NIH (LABS clinical trial partner) is part of Dept of Health

and Human Services.

If the infection in the lungs becomes rooted enough then traditional anti-virals do not work fast enough to save human lives from a cytokine storm.

The NIH has a paper published on it's website from 2022 showing that CBD-X provides an effective solution to down modulate the immune system in the event of a cytokine storm in human lungs.

SEDDS technology will acclerate absorption into the human body....lungs.

DEA rescheduled because of proven science and that science includes battling lung inflammation from influenza including avian.

Pidduck...you ready for the sh!t storm?

<< Previous

Bullboard Posts

Next >>

High-quality lithium projects in Argentina with drilling underway